# Dysport® Pediatric Lower Limb Spasticity Study

> **NCT01249417** · PHASE3 · COMPLETED · sponsor: **Ipsen** · enrollment: 241 (actual)

## Conditions studied

- Cerebral Palsy
- Muscle Spasticity
- Children

## Interventions

- **BIOLOGICAL:** Botulinum toxin type A
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01249417
- **Lead sponsor:** Ipsen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2014-02
- **Final completion:** 2014-06
- **Target enrollment:** 241 (ACTUAL)
- **Last updated:** 2022-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01249417

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01249417, "Dysport® Pediatric Lower Limb Spasticity Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01249417. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*